W 937 (Famotidine 40 mg)
Pill imprint W 937 has been identified as Famotidine 40 mg.
Famotidine is used in the treatment of gerd; erosive esophagitis; zollinger-ellison syndrome; indigestion; duodenal ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Famotidine 40 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for W 937 (Famotidine 40 mg)
- 40 mg
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Wockhardt USA
- National Drug Code (NDC):
- Inactive Ingredients:
- microcrystalline cellulose
low substituted hydroxypropyl cellulose
polyethylene glycol 400
|NDC Code||Manufacturer / Repackager|
|23490-5560||Palmetto State Pharmaceuticals Inc (repackager)|
|16590-0632||Stat RX USA LLC (repackager)|
Note: Inactive ingredients may vary.
More about famotidine
- Famotidine chewable tablets
- Famotidine solution
- Famotidine suspension
- Famotidine (Advanced Reading)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...